title: Response to comment on "cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humans".
authors.affiliation: Immuno-Oncology Platform, EMD Serono Research and Development Institute, Billerica, MA 01821; and Now Cancer Immunology Group, Agenus, Lexington, MA 02421.
authors.forename: Jeremy D
authors.initials: JD
authors.lastname: Waight
authors.affiliation: Immuno-Oncology Platform, EMD Serono Research and Development Institute, Billerica, MA 01821; and Robert.Hofmeister@EMDSerono.com.
authors.forename: Robert
authors.initials: R
authors.lastname: Hofmeister
authors.affiliation: Immuno-Oncology Platform, EMD Serono Research and Development Institute, Billerica, MA 01821; and Now Cancer Immunology Group, Agenus, Lexington, MA 02421.
authors.forename: Nicholas S
authors.initials: NS
authors.lastname: Wilson
mesh_terms: D000818:Animals; D044127:Epigenesis, Genetic; D051858:Forkhead Transcription Factors / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism*
chemical_list: D051858:Forkhead Transcription Factors